Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 630,640 | 614,223 | 598,134 | 649,938 | 554,179 |
| Marketable Securities | 107,360 | 103,486 | 93,648 | 94,876 | 87,930 |
| Receivables | 368,603 | 335,354 | 344,989 | 345,734 | 350,762 |
| Inventories | 402,883 | 370,272 | 380,707 | 351,206 | 383,896 |
| Income taxes - deferred | N/A | N/A | N/A | 43,102 | N/A |
| TOTAL | $1,651,709 | $1,555,827 | $1,543,287 | $1,562,674 | $1,503,401 |
| Non-Current Assets | |||||
| PPE Net | 321,507 | 305,936 | 313,549 | 302,417 | 305,921 |
| Intangibles | 558,476 | 529,308 | 548,427 | 532,405 | 544,199 |
| Other Non-Current Assets | 150,512 | 136,053 | 141,609 | 138,357 | 124,685 |
| TOTAL | $1,030,495 | $971,297 | $1,003,585 | $973,179 | $974,805 |
| Total Assets | $2,682,204 | $2,527,124 | $2,546,872 | $2,535,853 | $2,478,206 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 99,120 | 95,161 | 99,160 | 92,988 | 92,381 |
| Accrued Expenses | 120,171 | 111,518 | 106,261 | 126,702 | 118,891 |
| Other current liabilities | 105,189 | 102,291 | 95,534 | 106,136 | 99,692 |
| TOTAL | $410,694 | $389,495 | $398,170 | $419,972 | $415,695 |
| Non-Current Liabilities | |||||
| Long Term Debt | 733,574 | 734,339 | 738,662 | 737,919 | 738,687 |
| Other Non-Current Liabilities | 109,483 | 99,994 | 108,586 | 55,195 | 54,159 |
| TOTAL | $843,378 | $834,897 | $847,779 | $836,668 | $834,840 |
| Total Liabilities | $1,254,072 | $1,224,392 | $1,245,949 | $1,256,640 | $1,250,535 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,799 | 27,668 | 27,595 | 27,547 | 27,483 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 1,113,779 | 1,069,015 | 1,031,058 | 996,197 | 958,335 |
| Other shareholders' equity | 164,214 | 92,981 | 134,926 | 152,569 | 144,250 |
| TOTAL | $1,428,132 | $1,302,732 | $1,300,923 | $1,279,213 | $1,227,671 |
| Total Liabilities And Equity | $2,682,204 | $2,527,124 | $2,546,872 | $2,535,853 | $2,478,206 |